Ye Lifang, Chang Chih-Chiang, Li Qian, Tintut Yin, Hsu Jeffrey J
Heart Center, Department of Cardiovascular Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou 310014, China.
Department of Medicine, University of California, 650 Charles E Young Dr. S, Center for Health Sciences, Room A2-237, Los Angeles, CA 90095, USA.
J Cardiovasc Dev Dis. 2024 Dec 22;11(12):410. doi: 10.3390/jcdd11120410.
The detection and assessment of atherosclerosis and cardiovascular calcification can inform risk stratification and therapies to reduce cardiovascular morbidity and mortality. In this review, we provide an overview of current and emerging imaging techniques for assessing atherosclerosis and cardiovascular calcification in animal models. Traditional imaging modalities, such as computed tomography (CT) and magnetic resonance imaging (MRI), offer non-invasive approaches of visualizing atherosclerotic calcification in vivo; integration of these techniques with positron emission tomography (PET) imaging adds molecular imaging capabilities, such as detection of metabolically active microcalcifications with F-sodium fluoride. Photoacoustic imaging provides high contrast that enables in vivo evaluation of plaque composition, yet this method is limited by optical penetration depth. Light-sheet fluorescence microscopy provides high-resolution, three-dimensional imaging of cardiovascular structures and has been used for ex vivo assessment of atherosclerotic calcification, but its limited tissue penetration and requisite complex sample preparation preclude its use in vivo to evaluate cardiac tissue. Overall, with these evolving imaging tools, our understanding of cardiovascular calcification development in animal models is improving, and the combination of traditional imaging techniques with emerging molecular imaging modalities will enhance our ability to investigate therapeutic strategies for atherosclerotic calcification.
动脉粥样硬化和心血管钙化的检测与评估可为风险分层及降低心血管发病率和死亡率的治疗提供依据。在本综述中,我们概述了用于评估动物模型中动脉粥样硬化和心血管钙化的现有及新兴成像技术。传统成像方式,如计算机断层扫描(CT)和磁共振成像(MRI),提供了在体内可视化动脉粥样硬化钙化的非侵入性方法;将这些技术与正电子发射断层扫描(PET)成像相结合可增加分子成像能力,例如用氟[18F]氟化钠检测代谢活跃的微钙化。光声成像提供高对比度,能够在体内评估斑块成分,但该方法受光学穿透深度限制。光片荧光显微镜可对心血管结构进行高分辨率三维成像,并已用于动脉粥样硬化钙化的离体评估,但其有限的组织穿透性和复杂的样本制备要求使其无法用于体内评估心脏组织。总体而言,随着这些不断发展的成像工具,我们对动物模型中心血管钙化发展的理解正在改善,传统成像技术与新兴分子成像方式的结合将增强我们研究动脉粥样硬化钙化治疗策略的能力。